Our Approach

Neurolink has developed a drug-device combination therapy for the treatment of epilepsy. The Neurolink therapy delivers a powerful pharmacologic agent to the brain in small quantities through the implanted device. Local drug delivery eliminates systemic side effects such as sedation, and dramatically reduces - and potentially eliminates - seizures in certain patients. The Neurolink therapy also does not cause sedation.  With Neurolink's sensing technology, we will be able to track a patient's seizure history and develop predictive algorithms to anticipate the onset of a seizure and treat it before it happens.

Neurolink's approach is unlike any other treatment available today, and we believe there is potential for much higher efficacy rates without the undesirable side effects experienced with current therapies. The company is actively developing the technology and is conducting pre-clinical studies.